Works matching AU Hiroaki Itamochi

Results: 67

Clinical trials and future potential of targeted therapy for ovarian cancer.

Published in:

International Journal of Clinical Oncology, 2012, v. 17, n. 5, p. 430, doi. 10.1007/s10147-012-0459-8

By:

Itamochi, Hiroaki;
Kigawa, Junzo

Publication type:

Article

Chemotherapy consisting of paclitaxel and carboplatin benefits a patient with malignant mixed müllerian tumor of the fallopian tube.

Published in:

International Journal of Clinical Oncology, 2008, v. 13, n. 5, p. 461, doi. 10.1007/s10147-008-0767-1

By:

Kawaguchi, Wakae;
Itamochi, Hiroaki;
Kigawa, Junzo;
Kanamori, Yasunobu;
Oishi, Tetsuro;
Shimada, Muneaki;
Sato, Shinya;
Sato, Seiya;
Terakawa, Naoki

Publication type:

Article

Sex- and Age-Specific Associations Between Metabolic Syndrome and Future Functional Disability in the Japanese Older Population.

Published in:

Inquiry (00469580), 2024, p. 1, doi. 10.1177/00469580241273103

By:

Takahashi, Naomi;
Tsubota-Utsugi, Megumi;
Takahashi, Shuko;
Yonekura, Yuki;
Ohsawa, Masaki;
Kuribayashi, Toru;
Onoda, Toshiyuki;
Takanashi, Nobuyuki;
Sakata, Kiyomi;
Yamada, Takehiko;
Ogasawara, Kuniaki;
Omama, Shinichi;
Tanaka, Fumitaka;
Asahi, Koichi;
Ishigaki, Yasushi;
Itabashi, Ryo;
Itamochi, Hiroaki;
Takahashi, Fumiaki;
Okayama, Akira;
Tanno, Kozo

Publication type:

Article

Genome-wide analysis of microRNA to evaluate prognostic markers in isolated cancer glands and surrounding stroma in high-grade serous ovarian carcinoma.

Published in:

Oncology Letters, 2020, v. 20, n. 6, p. N.PAG, doi. 10.3892/ol.2020.12198

By:

Sato, Chie;
Osakabe, Mitsumasa;
Nagasawa, Takayuki;
Suzuki, Hiromu;
Itamochi, Hiroaki;
Baba, Tsukasa;
Sugai, Tamotsu

Publication type:

Article

Profile of farletuzumab and its potential in the treatment of solid tumors.

Published in:

OncoTargets & Therapy, 2016, v. 9, p. 1181, doi. 10.2147/OTT.S98242

By:

Seiya Sato;
Hiroaki Itamochi

Publication type:

Article

Primary rhabdomyosarcoma of the ethmoid sinus with orbital extension and metastasis to the pancreatic body.

Published in:

2022

By:

Itamochi, Hiroaki;
Ariga, Hisanori;
Shiga, Kiyoto;
Uesugi, Noriyuki;
Sugai, Tamotsu

Publication type:

Case Study

Somatic Copy Number Alterations Associated with Japanese or Endometriosis in Ovarian Clear Cell Adenocarcinoma.

Published in:

PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0116977

By:

Okamoto, Aikou;
Sehouli, Jalid;
Yanaihara, Nozomu;
Hirata, Yukihiro;
Braicu, Ioana;
Kim, Byoung-Gie;
Takakura, Satoshi;
Saito, Misato;
Yanagida, Satoshi;
Takenaka, Masataka;
Yamaguchi, Noriko;
Morikawa, Asuka;
Tanabe, Hiroshi;
Yamada, Kyosuke;
Yoshihara, Kosuke;
Enomoto, Takayuki;
Itamochi, Hiroaki;
Kigawa, Junzo;
Matsumura, Noriomi;
Konishi, Ikuo

Publication type:

Article

Mechanisms of Cisplatin Resistance in Clear Cell Carcinoma of the Ovary.

Published in:

Oncology, 2002, v. 62, n. 4, p. 349, doi. 10.1159/000065067

By:

Itamochi, Hiroaki;
Kigawa, Junzo;
Akeshima, Ryoji;
Sato, Shinya;
Kamazawa, Shunji;
Takahashi, Masakuni;
Kanamori, Yasunobu;
Suzuki, Mitsuaki;
Ohwada, Michitaka;
Terakawa, Naoki

Publication type:

Article

Cellular Efflux Pump and Interaction between Cisplatin and Paclitaxel in Ovarian Cancer Cells.

Published in:

Oncology, 2000, v. 59, n. 4, p. 329, doi. 10.1159/000012191

By:

Kamazawa, Shunji;
Kigawa, Junzo;
Minagawa, Yukihisa;
Itamochi, Hiroaki;
Shimada, Muneaki;
Takahashi, Masakuni;
Sato, Shinya;
Akeshima, Ryouji;
Terakawa, Naoki

Publication type:

Article

Residual Disease and Presence of Human Papillomavirus after Conization.

Published in:

Oncology, 1998, v. 55, n. 6, p. 517, doi. 10.1159/000011905

By:

Kanamori, Yasunobu;
Kigawa, Junzo;
Minagawa, Yukihisa;
Irie, Takashi;
Oishi, Testuro;
Itamochi, Hiroaki;
Cheng, Xiusi;
Terakawa, Naoki

Publication type:

Article

Measurement of endometrial thickness in premenopausal women in office gynecology.

Published in:

Reproductive Medicine & Biology, 2018, v. 17, n. 1, p. 29, doi. 10.1002/rmb2.12062

By:

Tsuda, Hiroshi;
Ito, Yoichi M.;
Todo, Yukiharu;
Iba, Takahiro;
Tasaka, Keiichi;
Sutou, Yuji;
Hirai, Kozo;
Dozono, Koichiro;
Dobashi, Yoshifusa;
Manabe, Mami;
Sakamoto, Tomomi;
Yamamoto, Ritsu;
Ueda, Katsufumi;
Akatsuka, Moe;
Kiyozuka, Yasuhiko;
Nagai, Nobutaka;
Imai, Manami;
Kobiki, Koji;
Fujita, Hiromasa;
Itamochi, Hiroaki

Publication type:

Article

Niraparib in Japanese patients with platinum-sensitive recurrent ovarian cancer: final results of a multicenter phase 2 study.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e115

By:

Hiroaki Itamochi;
Nobuhiro Takeshima;
Junzo Hamanishi;
Kosei Hasegawa;
Motoki Matsuura;
Kiyonori Miura;
Shoji Nagao;
Hidekatsu Nakai;
Naotake Tanaka;
Hideki Tokunaga;
Shin Nishio;
Hidemichi Watari;
Yoshihito Yokoyama;
Yoichi Kase;
Shuuji Sumino;
Ai Kato;
Ajit Suri;
Toshiaki Yasuoka;
Kazuhiro Takehara

Publication type:

Article

Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer.

Published in:

Journal of Gynecologic Oncology, 2021, v. 32, n. 2, p. 1, doi. 10.3802/jgo.2021.32.e21

By:

Kazuhiro Takehara;
Takashi Matsumoto;
Junzo Hamanishi;
Kosei Hasegawa;
Motoki Matsuura;
Kiyonori Miura;
Shoji Nagao;
Hidekatsu Nakai;
Naotake Tanaka;
Hideki Tokunaga;
Kimio Ushijima;
Hidemichi Watari;
Yoshihito Yokoyama;
Yoichi Kase;
Shuuji Sumino;
Suri, Ajit;
Hiroaki Itamochi;
Nobuhiro Takeshima

Publication type:

Article

Surgical management of non-invasive uterine clear cell carcinoma.

Published in:

Journal of Gynecologic Oncology, 2017, v. 28, n. 4, p. 1, doi. 10.3802/jgo.2017.28.e55

By:

Toru Sugiyama;
Satoshi Takeuchi;
Hiroaki Itamochi

Publication type:

Article

Comprehensive Genome Profiling‐Initiated Tumor‐Informed Circulating Tumor DNA Monitoring for Patients With Advanced Cancer.

Published in:

Cancer Science, 2025, v. 116, n. 3, p. 764, doi. 10.1111/cas.16446

By:

Sasaki, Taiga;
Hiraki, Hayato;
Yashima‐Abo, Akiko;
Nagashima, Hiromi;
Endo, Fumitaka;
Yaegashi, Mizunori;
Miura, Shimpei;
Obata, Keiko;
Yanagawa, Naoki;
Itamochi, Hiroaki;
Shirota, Hidekazu;
Iwaya, Takeshi;
Nishizuka, Satoshi S.

Publication type:

Article

Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE‐826.

Published in:

Cancer Science, 2022, v. 113, n. 11, p. 3877, doi. 10.1111/cas.15479

By:

Nishio, Shin;
Yonemori, Kan;
Usami, Tomoka;
Minobe, Shinichiro;
Yunokawa, Mayu;
Iwata, Takashi;
Okamoto, Aikou;
Aoki, Yoichi;
Itamochi, Hiroaki;
Takekuma, Munetaka;
Harano, Kenichi;
Yamamoto, Keiko;
Maruko, Takeshi;
Ugai, Hiroyuki;
Tekin, Cumhur;
Colombo, Nicoletta;
Fujiwara, Keiichi;
Hasegawa, Kosei;
Ushijima, Kimio

Publication type:

Article

Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: A potential treatment strategy.

Published in:

Cancer Science, 2009, v. 100, n. 3, p. 546, doi. 10.1111/j.1349-7006.2008.01065.x

By:

Sato, Seiya;
Itamochi, Hiroaki;
Kigawa, Junzo;
Oishi, Tetsuro;
Shimada, Muneaki;
Sato, Shinya;
Naniwa, Jun;
Uegaki, Kazunori;
Nonaka, Michiko;
Terakawa, Naoki

Publication type:

Article

Involvement of thioredoxin-binding protein 2 in the antitumor activity of CD437.

Published in:

Cancer Science, 2008, v. 99, n. 12, p. 2485, doi. 10.1111/j.1349-7006.2008.00979.x

By:

Matsuoka, Saori;
Tsuchiya, Hiroyuki;
Sakabe, Tomohiko;
Watanabe, Yumi;
Hoshikawa, Yoshiko;
Kurimasa, Akihiro;
Itamochi, Hiroaki;
Harada, Tasuku;
Terakawa, Naoki;
Masutani, Hiroshi;
Yodoi, Junji;
Shiota, Goshi

Publication type:

Article

Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma.

Published in:

Cancer Science, 2008, v. 99, n. 4, p. 653, doi. 10.1111/j.1349-7006.2008.00747.x

By:

Itamochi, Hiroaki;
Kigawa, Junzo;
Terakawa, Naoki

Publication type:

Article

Simultaneous inhibition of the mitogen-activated protein kinase kinase and phosphatidylinositol 3′-kinase pathways enhances sensitivity to paclitaxel in ovarian carcinoma.

Published in:

Cancer Science, 2007, v. 98, n. 12, p. 2002, doi. 10.1111/j.1349-7006.2007.00624.x

By:

Kawaguchi, Wakae;
Itamochi, Hiroaki;
Kigawa, Junzo;
Kanamori, Yasunobu;
Oishi, Tetsuro;
Shimada, Muneaki;
Sato, Sinya;
Shimogai, Ruri;
Sato, Seiya;
Terakawa, Naoki

Publication type:

Article

Predicting time to ovarian carcinoma recurrence using protein markers.

Published in:

Journal of Clinical Investigation, 2013, v. 123, n. 9, p. 3740, doi. 10.1172/JCI68509

By:

Ji-Yeon Yang;
Kosuke Yoshihara;
Kenichi Tanaka;
Masayuki Hatae;
Hideaki Masuzaki;
Hiroaki Itamochi;
Masashi Takano;
Kimio Ushijima;
Tanyi, Janos L.;
Coukos, George;
Yiling Lu;
Mills, Gordon B.;
Verhaak, Roel G. W.

Publication type:

Article

Area under the curve calculation of nedaplatin dose used in combination chemotherapy with irinotecan in a phase I study of gynecologic malignancies.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 33, doi. 10.1007/s00280-012-1885-z

By:

Shimada, Muneaki;
Fujiwara, Hiroyuki;
Sato, Shinya;
Oishi, Tetsuro;
Itamochi, Hiroaki;
Machida, Shizuo;
Takei, Yuji;
Harada, Tasuku;
Suzuki, Mitsuaki;
Kigawa, Junzo

Publication type:

Article

Evaluation of a formula for individual dosage of nedaplatin based on renal function.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 3, p. 599, doi. 10.1007/s00280-011-1739-0

By:

Sato, Shinya;
Fujiwara, Hiroyuki;
Oishi, Tetsuro;
Shimada, Muneaki;
Machida, Shizuo;
Takei, Yuji;
Itamochi, Hiroaki;
Suzuki, Mitsuaki;
Kigawa, Junzo

Publication type:

Article

Activity of docetaxel in paclitaxel-resistant ovarian cancer cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 3, p. 247, doi. 10.1007/s00280-003-0714-9

By:

Sato, Shinya;
Kigawa, Junzo;
Kanamori, Yasunobu;
Itamochi, Hiroaki;
Oishi, Tetsuro;
Shimada, Muneaki;
Iba, Takahiro;
Naniwa, Jun;
Uegaki, Kazunori;
Terakawa, Naoki

Publication type:

Article

PTEN is involved in the signal transduction pathway of contact inhibition in endometrial cells.

Published in:

Cell & Tissue Research, 2006, v. 323, n. 3, p. 523, doi. 10.1007/s00441-005-0082-3

By:

Uegaki, Kazunori;
Kanamori, Yasunobu;
Kigawa, Junzo;
Kawaguchi, Wakae;
Kaneko, Ruri;
Naniwa, Jun;
Takahashi, Masakuni;
Shimada, Muneaki;
Oishi, Tetsuro;
Itamochi, Hiroaki;
Terakawa, Naoki

Publication type:

Article

Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions.

Published in:

Oncogenesis, 2018, v. 7, n. 1, p. 1, doi. 10.1038/s41389-017-0018-2

By:

Tamura, Ryo;
Yoshihara, Kosuke;
Saito, Tetsuya;
Ishimura, Ryosuke;
Martínez-Ledesma, Juan Emmanuel;
Xin, Hu;
Ishiguro, Tatsuya;
Mori, Yutaro;
Yamawaki, Kaoru;
Suda, Kazuaki;
Sato, Seiya;
Itamochi, Hiroaki;
Motoyama, Teiichi;
Aoki, Yoichi;
Okuda, Shujiro;
Casingal, Cristine R.;
Nakaoka, Hirofumi;
Inoue, Ituro;
Verhaak, Roel G. W.;
Komatsu, Masaaki

Publication type:

Article

Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas.

Published in:

Cancers, 2021, v. 13, n. 23, p. 6120, doi. 10.3390/cancers13236120

By:

Shoji, Tadahiro;
Tatsuki, Shunsuke;
Abe, Marina;
Tomabechi, Hidetoshi;
Takatori, Eriko;
Kaido, Yoshitaka;
Nagasawa, Takayuki;
Kagabu, Masahiro;
Baba, Tsukasa;
Itamochi, Hiroaki

Publication type:

Article

Mesenteric extraovarian Sertoli-Leydig cell tumor without DICER1 hotspot mutation: a case report.

Published in:

Diagnostic Pathology, 2019, v. 14, n. 1, p. N.PAG, doi. 10.1186/s13000-019-0805-5

By:

Osakabe, Mitsumasa;
Sato, Chie;
Suzuki, Masamichi;
Sugimoto, Ryo;
Fujita, Yasuko;
Uesugi, Noriyuki;
Ishida, Kazuyuki;
Sugai, Tamotsu;
Itamochi, Hiroaki;
Baba, Tsukasa

Publication type:

Article

Establishment and characterization of a novel uterine carcinosarcoma cell line, TU-ECS-1, with mutations of TP53 and KRAS.

Published in:

Human Cell, 2017, v. 30, n. 2, p. 140, doi. 10.1007/s13577-016-0154-6

By:

Chiba, Yohei;
Sato, Seiya;
Itamochi, Hiroaki;
Suga, Yasuko;
Fukagawa, Tomoyuki;
Oumi, Nao;
Oishi, Tetsuro;
Harada, Tasuku;
Sugai, Tamotsu;
Sugiyama, Toru

Publication type:

Article

Establishment and characterization of a novel ovarian clear cell carcinoma cell line, TU-OC-2, with loss of ARID1A expression.

Published in:

Human Cell, 2016, v. 29, n. 4, p. 181, doi. 10.1007/s13577-016-0138-6

By:

Sato, Seiya;
Itamochi, Hiroaki;
Oumi, Nao;
Chiba, Youhei;
Oishi, Tetsuro;
Shimada, Muneaki;
Sato, Shinya;
Chikumi, Jun;
Nonaka, Michiko;
Kudoh, Akiko;
Komatsu, Hiroaki;
Harada, Tasuku;
Sugiyama, Toru

Publication type:

Article

Establishment and mutation analysis of a novel malignant peritoneal mesothelioma cell line, TU-MM-1, using whole genome sequencing.

Published in:

Human Cell, 2016, v. 29, n. 1, p. 46, doi. 10.1007/s13577-015-0120-8

By:

Oumi, Nao;
Itamochi, Hiroaki;
Komatsu, Hiroaki;
Oishi, Tetsuro;
Shimada, Muneaki;
Sato, Shinya;
Chikumi, Jun;
Sato, Seiya;
Nonaka, Michiko;
Kudoh, Akiko;
Harada, Tasuku

Publication type:

Article

Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.

Published in:

Human Cell, 2013, v. 26, n. 3, p. 121, doi. 10.1007/s13577-013-0062-y

By:

Itamochi, Hiroaki;
Kato, Misaki;
Nishimura, Mayumi;
Oumi, Nao;
Oishi, Tetsuro;
Shimada, Muneaki;
Sato, Shinya;
Naniwa, Jun;
Sato, Seiya;
Nonaka, Michiko;
Kudoh, Akiko;
Terakawa, Naoki;
Kigawa, Junzo;
Harada, Tasuku

Publication type:

Article

Establishment and characterization of a novel ovarian serous adenocarcinoma cell line, TU-OS-4, that overexpresses EGFR and HER2.

Published in:

Human Cell, 2012, v. 25, n. 4, p. 111, doi. 10.1007/s13577-012-0048-1

By:

Itamochi, Hiroaki;
Kato, Misaki;
Nishimura, Mayumi;
Oishi, Tetsuro;
Shimada, Muneaki;
Sato, Shinya;
Naniwa, Jun;
Sato, Seiya;
Nonaka, Michiko;
Kudoh, Akiko;
Terakawa, Naoki;
Kigawa, Junzo;
Harada, Tasuku

Publication type:

Article

An open-label, randomized, phase II trial evaluating the efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer patients previously treated with bevacizumab for front-line or platinum-sensitive ovarian cancer: rationale, design, and methods of the Japanese Gynecologic Oncology Group study JGOG3023.

Published in:

2018

By:

Shoji, Tadahiro;
Komiyama, Shinichi;
Kigawa, Junzo;
Tanabe, Hiroshi;
Kato, Kazuyoshi;
Itamochi, Hiroaki;
Fujiwara, Hiroyuki;
Kamiura, Shoji;
Hamano, Tetsutaro;
Sugiyama, Toru;
for the Japanese Gynecologic Oncology Group;
Japanese Gynecologic Oncology Group

Publication type:

journal article

Feasibility study on combination chemotherapy using nogitecan hydrochloride (topotecan) and cisplatin for patients with metastatic, persistent, or recurrent uterine cervical cancer.

Published in:

International Journal of Clinical Oncology, 2016, v. 21, n. 5, p. 969, doi. 10.1007/s10147-016-0984-y

By:

Shimada, Muneaki;
Sato, Shinya;
Oishi, Tetsuro;
Itamochi, Hiroaki;
Kigawa, Junzo;
Takeshima, Nobuhiro;
Aoki, Daisuke;
Aoki, Yoichi;
Nambu, Yoshihiro;
Ochiai, Kazunori

Publication type:

Article

Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.

Published in:

International Journal of Clinical Oncology, 2016, v. 21, n. 3, p. 580, doi. 10.1007/s10147-015-0929-x

By:

Kudoh, Akiko;
Sato, Shinya;
Itamochi, Hiroaki;
Komatsu, Hiroaki;
Nonaka, Michiko;
Sato, Seiya;
Chikumi, Jun;
Shimada, Muneaki;
Oishi, Tetsuro;
Kigawa, Junzo;
Harada, Tasuku

Publication type:

Article

Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary.

Published in:

International Journal of Clinical Oncology, 2015, v. 20, n. 5, p. 967, doi. 10.1007/s10147-015-0811-x

By:

Itamochi, Hiroaki;
Oumi, Nao;
Oishi, Tetsuro;
Shoji, Tadahiro;
Fujiwara, Hiroyuki;
Sugiyama, Toru;
Suzuki, Mitsuaki;
Kigawa, Junzo;
Harada, Tasuku

Publication type:

Article

Incidence and risk factors for lower limb lymphedema after gynecologic cancer surgery with initiation of periodic complex decongestive physiotherapy.

Published in:

International Journal of Clinical Oncology, 2015, v. 20, n. 3, p. 556, doi. 10.1007/s10147-014-0724-0

By:

Deura, Imari;
Shimada, Muneaki;
Hirashita, Keiko;
Sugimura, Maki;
Sato, Seiya;
Sato, Shinya;
Oishi, Tetsuro;
Itamochi, Hiroaki;
Harada, Tasuku;
Kigawa, Junzo

Publication type:

Article

Outcome of stage IB2-IIB patients with bulky uterine cervical cancer who underwent neoadjuvant chemotherapy followed by radical hysterectomy.

Published in:

International Journal of Clinical Oncology, 2014, v. 19, n. 2, p. 348, doi. 10.1007/s10147-013-0559-0

By:

Uegaki, Kazunori;
Shimada, Muneaki;
Sato, Seiya;
Deura, Imari;
Naniwa, Jun;
Sato, Shinya;
Oishi, Tetsuro;
Itamochi, Hiroaki;
Harada, Tasuku;
Kigawa, Junzo

Publication type:

Article

Clinical impact of systematic pelvic and para-aortic lymphadenectomy for pT1 and pT2 ovarian cancer: a retrospective survey by the Sankai Gynecology Study Group.

Published in:

International Journal of Clinical Oncology, 2013, v. 18, n. 6, p. 1107, doi. 10.1007/s10147-012-0483-8

By:

Oshita, Takafumi;
Itamochi, Hiroaki;
Nishimura, Ryuichiro;
Numa, Fumitaka;
Takehara, Kazuhiro;
Hiura, Masamichi;
Tanimoto, Hirotoshi;
Noma, Jun;
Hayase, Ryoji;
Murakami, Akihiro;
Fujimoto, Hideo;
Kanamori, Yasunobu;
Kitada, Fuminori;
Shitsukawa, Keiji;
Nagaji, Makoto;
Minagawa, Yukihisa;
Fujiwara, Michihisa;
Kigawa, Junzo

Publication type:

Article

Feasibility study on biweekly paclitaxel treatment as maintenance chemotherapy in advanced müllerian carcinoma.

Published in:

2012

By:

Minagawa, Yukihisa;
Shimada, Muneaki;
Itamochi, Hiroaki;
Sato, Shinya;
Sato, Seiya;
Okada, Makoto;
Kitada, Fuminori;
Kigawa, Junzo

Publication type:

Journal Article

Feasibility Study on Biweekly Paclitaxel Treatment as Maintenance Chemotherapy in Advanced Müllerian Carcinoma.

Published in:

Gynecologic & Obstetric Investigation, 2012, v. 73, n. 4, p. 272, doi. 10.1159/000332368

By:

Minagawa, Yukihisa;
Shimada, Muneaki;
Itamochi, Hiroaki;
Sato, Shinya;
Sato, Seiya;
Okada, Makoto;
Kitada, Fuminori;
Kigawa, Junzo

Publication type:

Article

Alteration of telomerase activity in ovarian cancer after chemotherapy.

Published in:

2000

By:

Takahashi, Masakuni;
Kigawa, Junzo;
Oishi, Tetsuro;
Itamochi, Hiroaki;
Shimada, Muneaki;
Sato, Shinya;
Kamazawa, Shunji;
Akeshima, Ryouji;
Terakawa, Naoki;
Takahashi, M;
Kigawa, J;
Oishi, T;
Itamochi, H;
Shimada, M;
Sato, S;
Kamazawa, S;
Akeshima, R;
Terakawa, N

Publication type:

journal article

Clinical responses and platinum concentrations in tumors after intra-arterial and intravenous administration of cisplatin in the same patients with cervical cancer.

Published in:

1997

By:

Kanamori, Yasunobu;
Kigawa, Junzo;
Minagawa, Yukihisa;
Irie, Takashi;
Itamochi, Hiroaki;
Cheng, Xiusi;
Okada, Makoto;
Terakawa, Naoki;
Kanamori, Y;
Kigawa, J;
Minagawa, Y;
Irie, T;
Itamochi, H;
Cheng, X;
Okada, M;
Terakawa, N

Publication type:

journal article

Combination effect of granisetron and methylprednisolone for preventing emesis induced by cytotoxic agents.

Published in:

1997

By:

Kigawa, Junzo;
Minagawa, Yukihisa;
Itamochi, Hiroaki;
Cheng, Xiusi;
Okada, Makoto;
Terakawa, Naoki;
Kigawa, J;
Minagawa, Y;
Itamochi, H;
Cheng, X;
Okada, M;
Terakawa, N

Publication type:

journal article

Influence of menopause on the cell kinetics of normal, hyperplastic, and malignant endometrium.

Published in:

1995

By:

Ishihara, Hiroshi;
Itamochi, Hiroaki;
Ishihara, H;
Itamochi, H

Publication type:

journal article

Contribution of transcription factor, SP1, to the promotion of HB- EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma.

Published in:

Cancer Medicine, 2014, v. 3, n. 5, p. 1159, doi. 10.1002/cam4.301

By:

Miyata, Kohei;
Yotsumoto, Fusanori;
Nam, Sung Ouk;
Odawara, Takashi;
Manabe, Sadao;
Ishikawa, Toyokazu;
Itamochi, Hiroaki;
Kigawa, Junzo;
Takada, Shuji;
Asahara, Hiroshi;
Kuroki, Masahide;
Miyamoto, Shingo

Publication type:

Article

Y-box binding protein 1/cyclin A1 axis specifically promotes cell cycle progression at G<sub>2</sub>/M phase in ovarian cancer.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-72174-9

By:

Murakami, Yuichi;
Katsuchi, Daisuke;
Matsumoto, Taichi;
Kanazawa, Kuon;
Shibata, Tomohiro;
Kawahara, Akihiko;
Akiba, Jun;
Yanaihara, Nozomu;
Okamoto, Aikou;
Itamochi, Hiroaki;
Sugiyama, Toru;
Terada, Atsumu;
Nishio, Shin;
Tsuda, Naotake;
Kato, Kiyoko;
Ono, Mayumi;
Kuwano, Michihiko

Publication type:

Article

Nedaplatin: a cisplatin derivative in cancer chemotherapy.

Published in:

Cancer Management & Research, 2013, v. 5, p. 67, doi. 10.2147/CMAR.S35785

By:

Muneaki Shimada;
Hiroaki Itamochi;
Junzo Kigawa

Publication type:

Article

The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinoma.

Published in:

Oncology Reports, 2014, v. 32, n. 2, p. 553, doi. 10.3892/or.2014.3268

By:

TETSURO OISHI;
HIROAKI ITAMOCHI;
AKIKO KUDOH;
MICHIKO NONAKA;
MISAKI KATO;
MAYUMI NISHIMURA;
NAO OUMI;
SEIYA SATO;
JUN NANIWA;
SHINYA SATO;
MUNEAKI SHIMADA;
JUNZO KIGAWA;
TASUKU HARADA

Publication type:

Article